IMP

Brigham and Women's Hospital was a founding member of The International Mesothelioma Program (IMP) when it was launched in 2002. The IMP is a collaborative research and treatment effort between Boston's finest medical institutions: BWH, Dana-Farber Cancer Institute, Massachusetts General Hospital, the Boston VA Health Care System and Harvard School of Public Health. The participating institutions combined goal is to develop treatment strategies that extend life, while also supporting patients physically, emotionally and practically throughout treatment... Our pulmonary medicine and thoracic surgery experts work in partnership with sub-specialists at BWH as needed and with the patient's community physician-a collaborative approach that ensures that every patient need is met as we diagnose and treat lung conditions. Pinpointing areas of emphasis, we deliver precise, personalized medicine focusing on each patient. This includes populations with specific needs, such as women and the..

Primary location: Boston United States